Baby formula will reportedly be in short supply well into July, even though Abbott Laboratories resumed production at its Sturgis, Michigan, factory Saturday, according to a report.
In a statement, Abbott said the Michigan plant will start with the production of “specialty and metabolic formulas, with initial EleCare product release to consumers beginning on or about June 20.”
The company will begin making Similac formula and other regular products after prioritizing the specialty formulas, “with supplies hitting stores several weeks later,” the Walls Street Journal reported, citing “a person familiar with the matter.”
Part of Abbott’s statement reads:
We understand the urgent need for formula and our top priority is getting high-quality, safe formula into the hands of families across America. We will ramp production as quickly as we can while meeting all…
